The Pennsylvania Supreme Court denied defendants' petition for allowance of appeal in Syngenta Crop Protection v. Nemeth, leaving unresolved the lingering uncertainty that has followed the U.S.

Spravato has been approved since 2019 for TRD, with its label extended the following year as a rescue therapy for adults with major depressive disorder (MDD) who were at risk of self-harm or suicide.

Johnson & Johnson has priced its new Spravato nasal spray for treatment-resistant depression (TRD) too high to offer value for money, says a US cost-effectiveness body. The Institute for Clinical ...

Subscribe to the UNHCR newsletter and join a global community that cares for the protection and well-being of refugees, internally displaced and stateless people. We’ll keep you up to date on ...